Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2012 (2012), Article ID 503165, 13 pages
http://dx.doi.org/10.1155/2012/503165
Research Article

Antiviral Ability of Kalanchoe gracilis Leaf Extract against Enterovirus 71 and Coxsackievirus A16

1School of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung 404, Taiwan
2Department of Medical Laboratory Science and Biotechnology, China Medical University, Taichung 404, Taiwan
3School of Pharmacy, China Medical University, Taichung 404, Taiwan
4Fujian Center for Disease Control and Prevention, Fujian, Fuzhou 350001, China
5Department of Nursing, Hungkuang University, Taichung 433, Taiwan
6Department of Biotechnology and Laboratory Science in Medicine, National Yang Ming University, Taipei 112, Taiwan
7Department of Biotechnology, Asia University, Wufeng, Taichung 413, Taiwan

Received 4 January 2012; Revised 5 March 2012; Accepted 12 March 2012

Academic Editor: Xiu-Min Li

Copyright © 2012 Ching-Ying Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. C. Kao, Handbook of Taiwan Medicinal Plants, Southern Materials Center, Taipei, Taiwan, 1981.
  2. Z. R. Lai, W. H. Peng, Y. L. Ho et al., “Analgesic and anti-inflammatory activities of the methanol extract of Kalanchoe gracilis (L.) DC stem in mice,” The American Journal of Chinese Medicine, vol. 38, no. 3, pp. 529–546, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. Z. R. Lai, Y. L. Ho, S. C. Hung et al., “Antioxidant, anti-inflammatory and antiproliferative activities of Kalanchoe gracilis (L.) DC stem,” The American Journal of Chinese Medicine, vol. 39, no. 6, pp. 1275–1290, 2011. View at Google Scholar
  4. C. S. L. Karin, S. L. Yang, M. F. Roberts, and J. D. Phillipson, “Eupafolin rhamnosides from Kalanchoe gracilis,” Journal of Natural Products, vol. 52, no. 5, pp. 970–974, 1989. View at Google Scholar · View at Scopus
  5. P. L. Wu, Y. L. Hsu, T. S. Wu, K. F. Bastow, and K. H. Lee, “Kalanchosides A-C, new cytotoxic bufadienolides from the aerial parts of Kalanchoe gracilis,” Organic Letters, vol. 8, no. 23, pp. 5207–5210, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. J. R. Hwu, R. Singha, S. C. Hong et al., “Synthesis of new benzimidazole-coumarin conjugates as anti-hepatitis C virus agents,” Antiviral Research, vol. 77, no. 2, pp. 157–162, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. C. C. Chiang, J. F. Mouscadet, H. J. Tsai, C. T. Liu, and L. Y. Hsu, “Synthesis and HIV-1 integrase inhibition of novel bis- or tetra-coumarin analogues,” Chemical and Pharmaceutical Bulletin, vol. 55, no. 12, pp. 1740–1743, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Liu, X. J. Cong, P. Li, J. J. Tan, W. Z. Chen, and C. X. Wang, “Study on the inhibitory mechanism and binding mode of the hydroxycoumarin compound NSC158393 to HIV-1 integraseby molecular modeling,” Biopolymers, vol. 91, no. 9, pp. 700–709, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. J. R. Hwu, S. Y. Lin, S. C. Tsay, E. De Clercq, P. Leyssen, and J. Neyts, “Coumarin-purine ribofuranoside conjugates as new agents against hepatitis c virus,” Journal of Medicinal Chemistry, vol. 54, no. 7, pp. 2114–2126, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. E. B. B. Ong, N. Watanabe, A. Saito et al., “Vipirinin, a coumarin-based HIV-1 Vpr inhibitor, interacts with a hydrophobic region of Vpr,” Journal of Biological Chemistry, vol. 286, no. 16, pp. 14049–14056, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Conti, P. Tomao, D. Genovese, N. Desideri, M. L. Stein, and N. Orsi, “Mechanism of action of the antirhinovirus flavanoid 4,6-dicyanoflavan,” Antimicrobial Agents and Chemotherapy, vol. 36, no. 1, pp. 95–99, 1992. View at Google Scholar · View at Scopus
  12. C. Conti, D. Genovese, R. Santoro, M. L. Stein, N. Orsi, and L. Fiore, “Activities and mechanisms of action of halogen-substituted flavanoids against poliovirus type 2 infection in vitro,” Antimicrobial Agents and Chemotherapy, vol. 34, no. 3, pp. 460–466, 1990. View at Google Scholar · View at Scopus
  13. D. Genovese, C. Conti, P. Tomao et al., “Effect of chloro-, cyano-, and amidino-substituted flavanoids on enterovirus infection in vitro,” Antiviral Research, vol. 27, no. 1-2, pp. 123–136, 1995. View at Publisher · View at Google Scholar · View at Scopus
  14. A. L. Salvati, A. De Dominicis, S. Tait, A. Canitano, A. Lahm, and L. Fiore, “Mechanism of action at the molecular level of the antiviral drug 3(2H)-isoflavene against type 2 poliovirus,” Antimicrobial Agents and Chemotherapy, vol. 48, no. 6, pp. 2233–2243, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. R. A. Mothana, R. Mentel, C. Reiss, and U. Lindequist, “Phytochemical screening and antiviral activity of some medicinal plants from the island Soqotra,” Phytotherapy Research, vol. 20, no. 4, pp. 298–302, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. U. Supratman, T. Fujita, K. Akiyama et al., “Anti-tumor promoting activity of bufadienolides from Kalanchoe pinnata and K. Daigremontiana × tubiflora,” Bioscience, Biotechnology and Biochemistry, vol. 65, no. 4, pp. 947–949, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. D. N. Knipe, P. M. Howley, D. E. Griffin et al., Enteroviruses: Polioviruses, Coxsackieviruses, Echoviruses, and Newer Enteroviruses. Fields Virology, vol. 1, 5th edition, 2007, Edited by Pallansch M. A. and Roos R. P.
  18. S. Singh, V. T. Chow, M. C. Phoon, K. P. Chan, and C. L. Poh, “Direct detection of enterovirus 71 (EV71) in clinical specimens from a hand, foot, and mouth disease outbreak in Singapore by reverse transcription-PCR with universal enterovirus and EV71-specific primers,” Journal of Clinical Microbiology, vol. 40, no. 8, pp. 2823–2827, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Zeng, F. Wen, Y. Gan, and W. Huang, “MRI and associated clinical characteristics of EV71-induced brainstem encephalitis in children with hand-foot-mouth disease,” Neuroradiology. In press. View at Publisher · View at Google Scholar
  20. S. A. Sanders, L. J. Herrero, K. McPhie et al., “Molecular epidemiology of enterovirus 71 over two decades in an Australian urban community,” Archives of Virology, vol. 151, no. 5, pp. 1003–1013, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. K. H. Lin, K. P. Hwang, G. M. Ke et al., “Evolution of EV71 genogroup in Taiwan from 1998 to 2005: an emerging of subgenogroup C4 of EV71,” Journal of Medical Virology, vol. 78, no. 2, pp. 254–262, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. B. Yang, H. Chuang, and K. D. Yang, “Sialylated glycans as receptor and inhibitor of enterovirus 71 infection to DLD-1 intestinal cells,” Virology Journal, vol. 6, pp. 141–146, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Y. Chang, T. Y. Lin, K. H. Hsu et al., “Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease,” The Lancet, vol. 354, no. 9191, pp. 1682–1686, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Ho, E. R. Chen, K. H. Hsu et al., “An epidemic of enterovirus 71 infection in Taiwan,” The New England Journal of Medicine, vol. 341, no. 13, pp. 929–935, 1999. View at Publisher · View at Google Scholar · View at Scopus
  25. C. C. Huang, C. C. Liu, Y. C. Chang, C. Y. Chen, S. T. Wang, and T. F. Yeh, “Neurologic complications in children with enterovirus 71 infection,” The New England Journal of Medicine, vol. 341, no. 13, pp. 936–942, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Y. Lin, S. H. Hsia, Y. C. Huang, C. T. Wu, and L. Y. Chang, “Proinflammatory cytokine reactions in enterovirus 71 infections of the central nervous system,” Clinical Infectious Diseases, vol. 36, no. 3, pp. 269–274, 2003. View at Google Scholar
  27. Y. Podin, E. L. Gias, F. Ong et al., “Sentinel surveillance for human enterovirus 71 in Sarawak, Malaysia: lessons from the first 7 years,” BMC Public Health, vol. 6, pp. 180–189, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. F. B. Yen, L. Y. Chang, C. L. Kao et al., “Coxsackieviruses infection in northern Taiwan—epidemiology and clinical characteristics,” Journal of Microbiology, Immunology and Infection, vol. 42, no. 1, pp. 38–46, 2009. View at Google Scholar · View at Scopus
  29. M. T. Tsai, Y. H. Cheng, Y. N. Liu, N. C. Liao, W. W. Lu, and S. H. Kung, “Real-time monitoring of human enterovirus (HEV)-infected cells and anti-HEV 3C protease potency by fluorescence resonance energy transfer,” Antimicrobial Agents and Chemotherapy, vol. 53, no. 2, pp. 748–755, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. M. S. Oberste, S. Peñaranda, S. L. Rogers, E. Henderson, and W. A. Nix, “Comparative evaluation of Taqman real-time PCR and semi-nested VP1 PCR for detection of enteroviruses in clinical specimens,” Journal of Clinical Virology, vol. 49, no. 1, pp. 73–74, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Castelló, E. Alvarez, and L. Carrasco, “The multifaceted poliovirus 2A protease: regulation of gene expression by picornavirus proteases,” Journal of Biomedicine and Biotechnology, vol. 2011, Article ID 369648, 23 pages, 2011. View at Publisher · View at Google Scholar
  32. R. L. Kuo, S. H. Kung, Y. Y. Hsu, and W. T. Liu, “Infection with enterovirus 71 or expression of its 24 protease induces apoptotic cell death,” Journal of General Virology, vol. 83, no. 6, pp. 1367–1376, 2002. View at Google Scholar · View at Scopus
  33. T. Ibrahim, J. M. Cunha, K. Madi, L. M. da Fonseca, S. S. Costa, and K. V. L. Gonçalves Koatz, “Immunomodulatory and anti-inflammatory effects of Kalanchoe brasiliensis,” International Immunopharmacology, vol. 2, no. 7, pp. 875–883, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. H. J. Choi, J. H. Song, K. S. Park, and S. H. Baek, “In vitro anti-enterovirus 71 activity of gallic acid from Woodfordia fruticosa flowers,” Letters in Applied Microbiology, vol. 50, no. 4, pp. 438–440, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. S. R. Shih, K. N. Tsai, Y. S. Li, C. C. Chueh, and E. C. Chan, “Inhibition of enterovirus 71-induced apoptosis by allophycocyanin isolated from a blue-green alga Spirulina platensis,” Journal of Medical Virology, vol. 70, no. 1, pp. 119–125, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. Q. C. Zhu, Y. Wang, Y. P. Liu et al., “Inhibition of enterovirus 71 replication by chrysosplenetin and penduletin,” European Journal of Pharmaceutical Sciences, vol. 44, no. 3, pp. 392–398, 2011. View at Google Scholar
  37. C. W. Lin, C. F. Wu, N. W. Hsiao et al., “Aloe-emodin is an interferon-inducing agent with antiviral activity against Japanese encephalitis virus and enterovirus 71,” International Journal of Antimicrobial Agents, vol. 32, no. 4, pp. 355–359, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Y. Lin, Y. C. Liu, J. R. Jheng et al., “Anti-enterovirus 71 activity screening of Chinese herbs with anti-infection and inflammation activities,” American Journal of Chinese Medicine, vol. 37, no. 1, pp. 143–158, 2009. View at Google Scholar · View at Scopus
  39. B. W. Wu, T. L. Pan, Y. L. Leu et al., “Antiviral effects of Salvia miltiorrhiza (Danshen) against enterovirus 71,” The American Journal of Chinese Medicine, vol. 35, no. 1, pp. 153–168, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. F. M. Su, J. S. Chang, K. C. Wang, J. J. Tsai, and L. C. Chiang, “A water extract of Pueraria lobata inhibited cytotoxicity of enterovirus 71 in a human foreskin fibroblast cell line,” Kaohsiung Journal of Medical Sciences, vol. 24, no. 10, pp. 523–530, 2008. View at Google Scholar · View at Scopus
  41. K. K. Kuo, J. S. Chang, K. C. Wang, and L. C. Chiang, “Water extract of Glycyrrhiza uralensis inhibited enterovirus 71 in a human foreskin fibroblast cell line,” The American Journal of Chinese Medicine, vol. 37, no. 2, pp. 383–394, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. L. Y. Chang, Y. C. Huang, and T. Y. Lin, “Fulminant neurogenic pulmonary oedema with hand, foot, and mouth disease,” The Lancet, vol. 352, no. 9125, pp. 367–368, 1998. View at Publisher · View at Google Scholar · View at Scopus
  43. S. M. Wang, H. Y. Lei, K. J. Huang et al., “Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema,” The Journal of Infectious Diseases, vol. 188, no. 4, pp. 564–570, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. S. M. Wang, H. Y. Lei, L. Y. Su et al., “Cerebrospinal fluid cytokines in enterovirus 71 brain stem encephalitis and echovirus meningitis infections of varying severity,” Clinical Microbiology and Infection, vol. 13, no. 7, pp. 677–682, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. T. Y. Lin, L. Y. Chang, Y. C. Huang, K. H. Hsu, C. H. Chiu, and K. D. Yang, “Different proinflammatory reactions in fatal and non-fatal enterovirus 71 infections: implications for early recognition and therapy,” Acta Paediatrica, vol. 91, no. 6, pp. 632–635, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. K. F. Weng, L. L. Chen, P. N. Huang, and S. R. Shih, “Neural pathogenesis of enterovirus 71 infection,” Microbes and Infection, vol. 12, no. 7, pp. 505–510, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. W. X. Khong, D. G. Foo, S. L. Trasti, E. L. Tan, and S. Alonso, “Sustained high levels of interleukin-6 contribute to the pathogenesis of enterovirus 71 in a neonate mouse model,” Journal of Virology, vol. 85, no. 7, pp. 3067–3076, 2011. View at Publisher · View at Google Scholar · View at Scopus